II

Jackson A Baril1,2, Karl Y Bilimoria1,2, Eugene P Ceppa2

  • 1Surgical Outcomes and Quality Improvement Center (SOQIC), Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.

PubMed
概括

辅助化疗 (AC) 改善了II期小肠腺癌 (SBA) 患者的存活率,这些患者有不充分的淋巴切除术和高危特征. 在没有这些额外风险因素的患者中,AC并没有显著影响存活率.